Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment

Intestinal microbiota and barrier functions seem to play an important role in the development of non-alcoholic fatty liver disease (NAFLD). However, whether these changes are an early event in the development of NAFLD or are primarily associated with later stages of the disease, has not yet been cla...

Full description

Bibliographic Details
Main Authors: Annette Brandt, Cheng Jun Jin, Katja Nolte, Cathrin Sellmann, Anna Janina Engstler, Ina Bergheim
Format: Article
Language:English
Published: MDPI AG 2017-09-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/9/9/1013
id doaj-bda33f94983e4fccaa5632639f4b90ff
record_format Article
spelling doaj-bda33f94983e4fccaa5632639f4b90ff2020-11-25T00:09:36ZengMDPI AGNutrients2072-66432017-09-0199101310.3390/nu9091013nu9091013Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic TreatmentAnnette Brandt0Cheng Jun Jin1Katja Nolte2Cathrin Sellmann3Anna Janina Engstler4Ina Bergheim5Department of Nutritional Sciences, Molecular Nutritional Science, University of Vienna, A-1090 Vienna, AustriaInstitute of Nutritional Sciences, SD Model Systems of Molecular Nutrition, Friedrich-Schiller-University Jena, D-07743 Jena, GermanyInstitute of Nutritional Sciences, SD Model Systems of Molecular Nutrition, Friedrich-Schiller-University Jena, D-07743 Jena, GermanyInstitute of Nutritional Sciences, SD Model Systems of Molecular Nutrition, Friedrich-Schiller-University Jena, D-07743 Jena, GermanyDepartment of Nutritional Sciences, Molecular Nutritional Science, University of Vienna, A-1090 Vienna, AustriaDepartment of Nutritional Sciences, Molecular Nutritional Science, University of Vienna, A-1090 Vienna, AustriaIntestinal microbiota and barrier functions seem to play an important role in the development of non-alcoholic fatty liver disease (NAFLD). However, whether these changes are an early event in the development of NAFLD or are primarily associated with later stages of the disease, has not yet been clarified. Using a pair-feeding model, we determined the effects of a short-term intake of a fat-, fructose- and cholesterol-rich diet (FFC) on the development of early hepatic steatosis and markers of intestinal barrier function in mice treated with and without non-resorbable antibiotics (AB). For four days, C57BL/6J mice were either pair-fed a control diet or a FFC diet ± AB (92 mg/kg body weight (BW) polymyxin B and 216 mg/kg BW neomycin). Hepatic steatosis and markers of inflammation, lipidperoxidation and intestinal barrier function were assessed. Lipid accumulation and early signs of inflammation found in the livers of FFC-fed mice were markedly attenuated in FFC + AB-fed animals. In FFC-fed mice the development of NAFLD was associated with a significant loss of tight junction proteins and an induction of matrix metalloproteinase-13 in the upper parts of the small intestine as well as significantly higher portal endotoxin levels and an induction of dependent signaling cascades in the liver. As expected, portal endotoxin levels and the expression of dependent signaling cascades in liver tissue were almost at the level of controls in FFC + AB-fed mice. However, FFC + AB-fed mice were also protected from the loss of zonula occludens-1 and partially of occludin protein in small intestine. Our data suggest that the development of early diet-induced hepatic steatosis in mice at least in part results from alterations of intestinal barrier function.https://www.mdpi.com/2072-6643/9/9/1013steatosisNAFLDantibioticsintestinal permeabilitymicrobiota
collection DOAJ
language English
format Article
sources DOAJ
author Annette Brandt
Cheng Jun Jin
Katja Nolte
Cathrin Sellmann
Anna Janina Engstler
Ina Bergheim
spellingShingle Annette Brandt
Cheng Jun Jin
Katja Nolte
Cathrin Sellmann
Anna Janina Engstler
Ina Bergheim
Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment
Nutrients
steatosis
NAFLD
antibiotics
intestinal permeability
microbiota
author_facet Annette Brandt
Cheng Jun Jin
Katja Nolte
Cathrin Sellmann
Anna Janina Engstler
Ina Bergheim
author_sort Annette Brandt
title Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment
title_short Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment
title_full Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment
title_fullStr Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment
title_full_unstemmed Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment
title_sort short-term intake of a fructose-, fat- and cholesterol-rich diet causes hepatic steatosis in mice: effect of antibiotic treatment
publisher MDPI AG
series Nutrients
issn 2072-6643
publishDate 2017-09-01
description Intestinal microbiota and barrier functions seem to play an important role in the development of non-alcoholic fatty liver disease (NAFLD). However, whether these changes are an early event in the development of NAFLD or are primarily associated with later stages of the disease, has not yet been clarified. Using a pair-feeding model, we determined the effects of a short-term intake of a fat-, fructose- and cholesterol-rich diet (FFC) on the development of early hepatic steatosis and markers of intestinal barrier function in mice treated with and without non-resorbable antibiotics (AB). For four days, C57BL/6J mice were either pair-fed a control diet or a FFC diet ± AB (92 mg/kg body weight (BW) polymyxin B and 216 mg/kg BW neomycin). Hepatic steatosis and markers of inflammation, lipidperoxidation and intestinal barrier function were assessed. Lipid accumulation and early signs of inflammation found in the livers of FFC-fed mice were markedly attenuated in FFC + AB-fed animals. In FFC-fed mice the development of NAFLD was associated with a significant loss of tight junction proteins and an induction of matrix metalloproteinase-13 in the upper parts of the small intestine as well as significantly higher portal endotoxin levels and an induction of dependent signaling cascades in the liver. As expected, portal endotoxin levels and the expression of dependent signaling cascades in liver tissue were almost at the level of controls in FFC + AB-fed mice. However, FFC + AB-fed mice were also protected from the loss of zonula occludens-1 and partially of occludin protein in small intestine. Our data suggest that the development of early diet-induced hepatic steatosis in mice at least in part results from alterations of intestinal barrier function.
topic steatosis
NAFLD
antibiotics
intestinal permeability
microbiota
url https://www.mdpi.com/2072-6643/9/9/1013
work_keys_str_mv AT annettebrandt shorttermintakeofafructosefatandcholesterolrichdietcauseshepaticsteatosisinmiceeffectofantibiotictreatment
AT chengjunjin shorttermintakeofafructosefatandcholesterolrichdietcauseshepaticsteatosisinmiceeffectofantibiotictreatment
AT katjanolte shorttermintakeofafructosefatandcholesterolrichdietcauseshepaticsteatosisinmiceeffectofantibiotictreatment
AT cathrinsellmann shorttermintakeofafructosefatandcholesterolrichdietcauseshepaticsteatosisinmiceeffectofantibiotictreatment
AT annajaninaengstler shorttermintakeofafructosefatandcholesterolrichdietcauseshepaticsteatosisinmiceeffectofantibiotictreatment
AT inabergheim shorttermintakeofafructosefatandcholesterolrichdietcauseshepaticsteatosisinmiceeffectofantibiotictreatment
_version_ 1725410899197427712